E-LIB Suche - Ergebnisse für: Schoenfeld, A.J.

1

Prospective Study of Plasma Biomarker-Guided Surveillance o..:

Rettig, E.M. ; Miller, J. ; Sargent, B....
International Journal of Radiation Oncology*Biology*Physics. 118 (2024) 5 - p. e50 , 2024

Link: https://doi.org/10.1016/..

2

P.026 Success with incrementally faster times to endovascul..:

Legere, B ; Mohamed, A ; Elsherif, S...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 51 (2024) s1 - p. S21-S22 , 2024

Link: https://doi.org/10.1017/..

3

A Phase 2 Clinical Trial of Pembrolizumab with Radiation Fo..:

Schoenfeld, J.D. ; Chen, Y.H. ; Gunasti, L....
International Journal of Radiation Oncology*Biology*Physics. 118 (2024) 5 - p. e32 , 2024

Link: https://doi.org/10.1016/..

4

Carotid intima-media thickness progression and plaque forma..:

Schoenfeld, J ; Schindler, M J ; Fegers-Wustrow, I...
European Journal of Preventive Cardiology. 31 (2024) Supplement_1 - p. , 2024

Link: https://doi.org/10.1093/..

5

229P Clinicopathologic and genomic features of patients wit..:

Di Federico, A. ; Hong, L. ; Elkrief, A....
ESMO Open. 9 (2024) - p. 102879 , 2024

Link: https://doi.org/10.1016/..

6

XRay Vision: A Phase 3 Study of Xevinapant Plus Radiotherap..:

Ferris, R.L. ; Mehanna, H. ; Schoenfeld, J.D....
International Journal of Radiation Oncology*Biology*Physics. 118 (2024) 5 - p. e17-e18 , 2024

Link: https://doi.org/10.1016/..

7

Nitric oxide metabolites in heart failure patients with red..:

Dinges, S M T ; Schoenfeld, J ; Mueller, S...
European Journal of Preventive Cardiology. 30 (2023) Supplement_1 - p. , 2023

Link: https://doi.org/10.1093/..

8

P2.05-14 Understanding Genomic and Social Determinants of C..:

Carrot-Zhang, J. ; Fong, C. ; Waters, M....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S313-S314 , 2023

Link: https://doi.org/10.1016/..

9

OA14.04 Three-Year Outcomes with First-Line Pembrolizumab, ..:

Ricciuti, B. ; Arielle Elkrief, A. ; Lin, J....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S77 , 2023

Link: https://doi.org/10.1016/..

10

P2.07-03 Factors Associated with Disease Progression after ..:

Pecci, F. ; Thummalapalli, R. ; Alden, S....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S323-S324 , 2023

Link: https://doi.org/10.1016/..

11

Automated Sarcopenia Assessment and Outcomes in Head and Ne..:

Saraf, A. ; Ye, Z. ; Likitlersuang, J....
International Journal of Radiation Oncology*Biology*Physics. 117 (2023) 2 - p. e623 , 2023

Link: https://doi.org/10.1016/..

12

MA15.08 Multicenter Phase II Trial of LN-145 TIL Cell Thera..:

Schoenfeld, A.J. ; He, K. ; Chesney, J....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S155 , 2023

Link: https://doi.org/10.1016/..

13

41P Efficacy of first-line (1L) nivolumab (N) + ipilimumab ..:

Borghaei, H. ; Balli, D. ; Paz-Ares, L....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S64-S65 , 2023

Link: https://doi.org/10.1016/..

14

Clinical and patient-reported outcomes of adult spinal defo..:

Tretiakov, P. ; Dave, P. ; Mir, J....
Brain and Spine. 3 (2023) - p. 102620 , 2023

Link: https://doi.org/10.1016/..

15

65O Phase III LEAP-008 study of lenvatinib plus pembrolizum..:

Leighl, N. ; Paz-Ares, L. ; Abreu, D. Rodriguez...
Immuno-Oncology and Technology. 20 (2023) - p. 100537 , 2023

Link: https://doi.org/10.1016/..